Th2 cytokines might have a key role in early phase of ILD in SSc patients and IL-4 was associated with DLco ≤ 60% of the predicted and with fibrotic involvement of ≥ 10% of lung parenchyma in SSc patients. The gene discussed is IL4; the disease is systemic sclerosis.